Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Keybank National Association OH

Keybank National Association OH trimmed its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 26.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,447 shares of the company's stock after selling 3,763 shares during the period. Keybank National Association OH's holdings in Prestige Consumer Healthcare were worth $816,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Charles Schwab Investment Management Inc. boosted its position in shares of Prestige Consumer Healthcare by 5.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock worth $49,667,000 after purchasing an additional 33,844 shares in the last quarter. Norden Group LLC raised its stake in Prestige Consumer Healthcare by 5.1% in the fourth quarter. Norden Group LLC now owns 14,465 shares of the company's stock valued at $1,130,000 after buying an additional 700 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in Prestige Consumer Healthcare by 29.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 4,237 shares of the company's stock worth $328,000 after acquiring an additional 964 shares in the last quarter. Bridges Investment Management Inc. purchased a new stake in shares of Prestige Consumer Healthcare during the fourth quarter worth about $213,000. Finally, QRG Capital Management Inc. increased its holdings in shares of Prestige Consumer Healthcare by 3.3% during the fourth quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock valued at $429,000 after acquiring an additional 176 shares in the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

Several analysts have weighed in on the stock. Oppenheimer boosted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Sidoti lowered shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price objective on the stock. in a report on Monday, December 9th. StockNews.com lowered Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Monday. Raymond James raised Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Finally, DA Davidson increased their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a report on Friday, February 7th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $92.60.

Prestige Consumer Healthcare Stock Performance

Shares of NYSE PBH traded down $2.15 during midday trading on Wednesday, reaching $82.94. 327,464 shares of the stock were exchanged, compared to its average volume of 334,504. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The firm has a market cap of $4.11 billion, a price-to-earnings ratio of 19.47, a PEG ratio of 2.69 and a beta of 0.46. The firm has a 50-day simple moving average of $81.13 and a two-hundred day simple moving average of $78.09. Prestige Consumer Healthcare Inc. has a twelve month low of $62.35 and a twelve month high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.